Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Health Systems and Reform|May 8, 2024
Fifteen Lessons from Fifteen Years of the Health Intervention and Technology Assessment Program in ThailandYot Teerawattananon, Saudamini Vishwanath Dabak, Anthony Culyer, et al.
BMJ (Clinical Research Ed.)|February 17, 2007
When are randomised trials unnecessary? Picking signal from noisePaul Glasziou, Iain Chalmers, Michael Rawlins, et al.
Journal of Health Services Research & Policy|January 25, 2007
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical ExcellenceAnthony Culyer, Christopher McCabe, Andrew Briggs, et al.
Health Economics|December 21, 2005
Discounting and cost-effectiveness in NICE - stepping back to sort out a confusionKarl Claxton, Mark Sculpher, Anthony Culyer, et al.
Journal of Clinical Epidemiology|July 16, 2005
Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparitiesGeoffrey M Anderson, Susan E Bronskill, Cameron A Mustard, et al.
Healthcare Policy = Politiques De Sante|February 2, 2012
Access to cancer drugs in Canada: looking beyond coverage decisionsRoger Chafe, Anthony Culyer, Mark Dobrow, et al.
International Journal of Technology Assessment in Health Care|June 3, 2022
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task ForceWija Oortwijn, Don Husereau, Julia Abelson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task ForceWija Oortwijn, Don Husereau, Julia Abelson, et al.
Gates Open Research|February 12, 2021
What next after GDP-based cost-effectiveness thresholds?Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, et al.
Pageof 3